Results 1 to 10 of about 1,946,462 (288)

Rare essentials: drugs for rare diseases as essential medicines

Bulletin of the World Health Organization, 2006
Since 1977, the WHO Model List of Essential Medicines (EML), published by WHO, has provided advice for Member States that struggle to decide which pharmaceutical technologies should be provided to patients within their public health systems.
Pieter Stolk, Marjolein JC Willemen, Hubert GM Leufkens   +2 more
doaj   +5 more sources

A third-line antiretroviral therapy register to track patient clinical and virological outcomes

South African Medical Journal, 2022
-
K Naidoo, J Ramruthan, M Reddy, R Lancaster   +3 more
doaj   +1 more source

Knowledge, attitude and practices of rational use of medicines among interns in a tertiary care teaching hospital in Telangana

Asian Journal of Medical Sciences, 2021
Background: Rational use of drugs significantly impacts the treatment outcomes and the cost of health care. Most of the medical students are exposed to rational use of medicines and prescription writing during their second year but it is only during ...
Kranti Tekulapally
doaj   +1 more source

Free acquisition of psychotropic drugs by the Brazilian adult population and presence on the National List of Essential Medicines [PDF]

Brazilian Journal of Pharmaceutical Sciences, 2022
The aims of the present study were to estimate the free-of-charge acquisition of psychotropic drugs among Brazilian adults; analyze the distribution of psychotropics according to their presence on the Relação Nacional de Medicamentos Essenciais (RENAME ...
Patrícia Silveira Rodrigues, Priscila Maria Stolses Bergamo Francisco, Andréia Turmina Fontanella, Karen Sarmento Costa   +3 more
doaj   +1 more source

Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary

Health Systems & Reform, 2021
Evidence shows that those with non-communicable diseases (NCDs) are at higher risk for serious illness and mortality from COVID-19. In Kenya, about 50% of the COVID-19 patients who have died had an NCD.
Zana Wangari Kiragu, Gladwell Gathecha, Martin K. Mwangi, Zachary Ndegwa, Sonak Pastakia, Daniel Nyagah, Richard N. Cizungu, Mariana Takah Mutwiri, Meshack Ndolo, Veronika J. Wirtz   +9 more
doaj   +1 more source

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

BMC Health Services Research, 2021
Background Cryptococcal meningitis in HIV-infected patients in sub-Saharan Africa accounts for three-quarters of the global cases and 135,000 deaths per annum. Current treatment includes the use of fluconazole and amphotericin B.
Jacqui Miot, Trudy Leong, Simbarashe Takuva, Andrew Parrish, Halima Dawood   +4 more
doaj   +1 more source

UNAVAILBILITY OF APPROPRIATE DOSES AND NEED FOR TABLET SPLITTING OF PSYCHOTROPIC DRUGS BY GERIATRIC PATIENTS

Geriatrics, Gerontology and Aging, 2020
BACKGROUND: Tablet splitting appears common in older adults, but its safety, and the factors associated with this practice, remain unclear. OBJECTIVE: To identify which psychotropic drugs are most often split, which doses are intended with this practice,
Flávio Mascarenhas Starling, Einstein Francisco Camargos, Felipe Ferreira, Marco Polo Dias Freitas, José Reinaldo Silva Costa, Patrícia Medeiros-Souza   +5 more
doaj   +1 more source

The global shortage of essential drugs during the COVID-19 pandemic: Evidence based on aggregated media and social media reports

Journal of Nature and Science of Medicine, 2022
Background: Implications from accumulated bodies of commentaries and media/social-media reports highlight the drug shortage during the COVID-19 pandemic. In this special report, the relation between drug shortage and response measures is discussed in the
Mohammed Salahuddin, Dilshad Manzar, Aleem Unissa, Seithikurippu R Pandi-Perumal, Ahmed S BaHammam   +4 more
doaj   +1 more source

Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB. [PDF]

, 2016
Repurposing has gained momentum globally and become an alternative avenue for drug discovery because of its better success rate, and reduced cost, time and issues related to safety than the conventional drug discovery process.
Brindha, Sridharan, Gnanadoss, John Joel, Sundaramurthi, Jagadish Chandrabose, Velmurugan, Devadasan, Vincent, Savariar   +4 more
core   +1 more source

Selection of psychotropic medications for the primary health care essential medicine list: Rationale and process

South African Journal of Psychiatry, 2018
Introduction: Equitable access to essential psychotropic medicines at primary level is fundamental to universal health coverage for mental health. It relies upon rational selection, affordable pricing, financial protection and consistent supply systems ...
Lesley J. Robertson, Renee De Waal, Trudy D. Leong   +2 more
doaj   +1 more source